Relationship between cardiac tissue glycation and skin autofluorescence in patients with coronary artery disease

Diabetes and Metabolism

Volumn 41, Issue 5, 2015, Pages 410-415

  Hofmann, B ^a   Jacobs, K ^a   Navarrete Santos, A ^a   Wienke, A ^b   Silber, R E ^a   Simm, A ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

AGEs; Coronary artery disease; Diabetes mellitus; Skin autofluorescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; COLLAGENASE; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYPROLINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGE; AGED; ARTICLE; AUTOFLUORESCENCE; BIOCHEMICAL ANALYSIS; BODY MASS; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ENZYME DEGRADATION; EUROSCORE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; GLYCATION; HEART; HEART ATRIUM APPENDAGE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; PROTEIN DEGRADATION; SKIN AUTOFLUORESCENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD; CAUCASIAN; CHEMISTRY; COMPLICATION; DIABETIC ANGIOPATHIES; FLUORESCENCE IMAGING; GERMANY; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; SKIN; SUBCUTANEOUS TISSUE; UPREGULATION; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; ATRIAL APPENDAGE; BIOMARKERS; COLLAGEN; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; GERMANY; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; OPTICAL IMAGING; PROSPECTIVE STUDIES; SKIN; SUBCUTANEOUS TISSUE; UP-REGULATION;

EID: 84946715371     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2014.12.001     Document Type: Article

References (33)

1. Hou L., Huang J., Green C.D., Boyd-Kirkup J., Zhang W., Yu X., et al. Systems biology in aging: linking the old and the young. Curr Genomics 2012, 13:558-565.
2. Hegab Z., Gibbons S., Neyses L., Mamas M.A. Role of advanced glycation end products in cardiovascular disease. World J Cardiol 2012, 4:90-102.
3. Greenwald S.E. Ageing of the conduit arteries. J Pathol 2007, 211:157-172.
4. Najjar S.S., Scuteri A., Lakatta E.G. Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension 2005, 46:454-462.
5. Tessier F.J. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol Biol (Paris) 2010, 58:214-219.
6. Simm A. Protein glycation during aging and in cardiovascular disease. J Proteomics 2013, 92:248-259.
7. Willemsen S., Hartog J.W., Hummel Y.M., van Ruijven M.H., van der Horst I.C., van Veldhuisen D.J., et al. Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients. Eur J Heart Fail 2011, 13:76-82.
8. Raposeiras-Roubin S., Rodino-Janeiro B.K., Paradela-Dobarro B., Grigorian-Shamagian L., Garcia-Acuna J.M., Aguiar-Souto P., et al. Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report. Cardiovasc Diabetol 2012, 11:102.
9. Badenhorst D., Maseko M., Tsotetsi O.J., Naidoo A., Brooksbank R., Norton G.R., et al. Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats. Cardiovasc Res 2003, 57:632-641.
10. Ueno H., Koyama H., Fukumoto S., Tanaka S., Shoji T., Emoto M., et al. Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease. Metabolism 2011, 60:453-459.
11. Yoon S.J., Park S., Shim C.Y., Park C.M., Ko Y.G., Choi D., et al. Association of RAGE gene polymorphisms with coronary artery disease in the Korean population. Coron Artery Dis 2007, 18:1-8.
12. Makulska I., Szczepanska M., Drozdz D., Polak-Jonkisz D., Zwolinska D. Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease. Pediatr Nephrol 2013, 28:121-128.
13. Meerwaldt R., Graaff R., Oomen P.H., Links T.P., Jager J.J., Alderson N.L., et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 2004, 47:1324-1330.
14. Meerwaldt R., Lutgers H.L., Links T.P., Graaff R., Baynes J.W., Gans R.O., et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007, 30:107-112.
15. Lutgers H.L., Gerrits E.G., Graaff R., Links T.P., Sluiter W.J., Gans R.O., et al. Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia 2009, 52:789-797.
16. McIntyre N.J., Fluck R.J., McIntyre C.W., Taal M.W. Skin autofluorescence and the association with renal and cardiovascular risk factors in chronic kidney disease stage 3. Clin J Am Soc Nephrol 2011, 6:2356-2363.
17. Mulder D.J., van Haelst P.L., Graaff R., Gans R.O., Zijlstra F., Smit A.J. Skin autofluorescence is elevated in acute myocardial infarction and is associated with the one-year incidence of major adverse cardiac events. Neth Heart J 2009, 17:162-168.
18. Noordzij M.J., Lefrandt J.D., Loeffen E.A., Saleem B.R., Meerwaldt R., Lutgers H.L., et al. Skin autofluorescence is increased in patients with carotid artery stenosis and peripheral artery disease. Int J Cardiovasc Imaging 2012, 28:431-438.
19. Ueno H., Koyama H., Tanaka S., Fukumoto S., Shinohara K., Shoji T., et al. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 2008, 57:1452-1457.
20. Hofmann B., Adam A.C., Jacobs K., Riemer M., Erbs C., Bushnaq H., et al. Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?. Exp Gerontol 2013, 48:38-44.
21. Rolewska P., Al-Robaiy S., Navarrete Santos A., Simm A., Silber R.E., Bartling B. Age-related expression, enzymatic solubility and modification with advanced glycation end-products of fibrillar collagens in mouse lung. Exp Gerontol 2013, 48:29-37.
22. Lin Y.K., Kuan C.Y. Development of 4-hydroxyproline analysis kit and its application to collagen quantification. Food Chem 2010, 28:1271-1277. [119].
23. Simm A., Navarrete-Santos B.B., Friedrich A., Scheubel I., Hofmann R.J., Bushnaq B., et al. Protein glycation - A biomarker of ageing or more?. International Proceedings - SFRR European Meeting 2008 2008, 31-38.
24. Nozynski J., Zakliczynski M., Konecka-Mrowka D., Zielinska T., Zakliczynska H., Nikiel B., et al. Advanced glycation end product accumulation in the cardiomyocytes of heart failure patients with and without diabetes. Ann Transplant 2012, 17:53-61.
25. Wolffenbuttel B.H., Giordano D., Founds H.W., Bucala R. Long-term assessment of glucose control by haemoglobin-AGE measurement. Lancet 1996, 347:513-515.
26. Kumari K., Sahib M.K. Susceptibility of different rat tissues to non-enzymatic protein glycosylation in experimental diabetes. Indian J Exp Biol 1993, 31:194-195.
27. Reddy G.K. AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats. Microvasc Res 2004, 68:132-142.
28. Nozynski J., Zakliczynski M., Konecka-Mrowka D., Zakliczynska H., Pijet M., Zembala-Nozynska E., et al. Advanced glycation end products and lipofuscin deposits share the same location in cardiocytes of the failing heart. Exp Gerontol 2013, 48:223-228.
29. Campbell D.J., Somaratne J.B., Jenkins A.J., Prior D.L., Yii M., Kenny J.F., et al. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease. Cardiovasc Diabetol 2011, 10:80.
30. Kilhovd B.K., Juutilainen A., Lehto S., Ronnemaa T., Torjesen P.A., Hanssen K.F., et al. Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18-year follow-up study. Diabetologia 2007, 50:1409-1417.
31. Hartog J.W., Hummel Y.M., Voors A.A., Schalkwijk C.G., Miyata T., Huisman R.M., et al. Skin autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients. J Card Fail 2008, 14:596-602.
32. Nin J.W., Jorsal A., Ferreira I., Schalkwijk C.G., Prins M.H., Parving H.H., et al. Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study. Diabetes Care 2011, 34:442-447.
33. Smit A.J., Gerrits E.G. Skin autofluorescence as a measure of advanced glycation endproduct deposition: a novel risk marker in chronic kidney disease. Curr Opin Nephrol Hypertens 2010, 19:527-533.